Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Khan Najat
CEO and President at RECURSION PHARMACEUTICALS. Filing since 18 Aug 2025.
CIK 0002020969
Company
Date
Role
Action
Shares
Amount
Of holding
RXRX
RECURSION PHARMACEUTICALS, INC.
8 Sep 2026
CEO and President
Sold on a plan
22,408
$78.82K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
5 Jun 2026
CEO and President
Sold on a plan
23,588
$84.46K
1.1%
RXRX
RECURSION PHARMACEUTICALS, INC.
9 Mar 2026
CEO and President
Sold on a plan
28,298
$94.66K
1.2%
RXRX
RECURSION PHARMACEUTICALS, INC.
22 Dec 2025
Chief R&D Commercial Officer
Sold on a plan
124,403
$548.59K
16.9%
RXRX
RECURSION PHARMACEUTICALS, INC.
18 Aug 2025
Chief R&D Commercial Officer
Sold at will
36,599
$202.17K
5.2%
5 decisions on file.
